GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Clinical trial NCT00110721 · TERMINATED

Trial details

NCT number: NCT00110721
Sponsor: Galectin Therapeutics Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2005-05-01
Primary completion: 2007-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.